| Literature DB >> 29576316 |
Joana G Rodrigues1, Meritxell Balmaña2, Joana A Macedo3, Juliana Poças4, Ângela Fernandes5, Julio Cesar M de-Freitas-Junior6, Salomé S Pinho7, Joana Gomes8, Ana Magalhães9, Catarina Gomes10, Stefan Mereiter11, Celso A Reis12.
Abstract
Tumour metastasis is the main cause of cancer related deaths. Metastasis is an intricate multi-step process that requires the acquisition of several cancer cell features, including the modulation of tumour cell migration, adhesion, invasion, and immune evasion. Changes in the cellular glycosylation are associated with malignant transformation of cancer cells, tumour progression and ultimately, metastasis formation. Glycans have major impact on cellular signalling and on the regulation of tumour cell-cell adhesion and cell-matrix interaction. Glycans drive the interplay between the cancer cells and the tumour microenvironment. In this review, we summarize the roles of glycan alterations in tumour progression, such as acquisition of oncogenic features due to modulation of receptor tyrosine kinases, proteoglycans, cadherins and integrins. We also highlight the importance of key glycan binding proteins such as selectins, siglecs and galectins, which are pivotal in the modulation of immune response. An overview on glycans as cancer biomarkers is also presented.Entities:
Keywords: Biomarkers; Cadherins; Galectins; Glycosylation in cancer; Integrins; Metastasis; Proteoglycans; Receptor tyrosine kinase; Selectins; Siglecs
Mesh:
Substances:
Year: 2018 PMID: 29576316 DOI: 10.1016/j.cellimm.2018.03.007
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868